创业慧康（300451）(300451.SZ)发布公告，持股5%以上股东飞利浦(中国)投资有限公司(简称"飞利浦") 计划自公告之日起十五个交易日后的3个月内(在此期间如遇法律、法规规定的窗口期则不减持)以集中 竞价方式和大宗交易方式合计减持公司股份不超过4633.28万股(含)，占剔除公司回购专用账户股份后总 股本比例3%。 ...

Group 1 - The core point of the article is that Philips (China) Investment Co., Ltd. plans to reduce its stake in Chuangye Huikang (300451) by up to 46.33 million shares, which represents 3% of the total share capital after excluding shares held in the company's repurchase account [1] Group 2 - The reduction will be executed through centralized bidding and block trading methods [1] - The announcement was made on the evening of August 5 [1] - The total number of shares to be reduced is significant, indicating a potential shift in shareholder strategy [1]

Group 1 - Philips (China) Investment Co., Ltd., a shareholder holding more than 5%, plans to reduce its stake in Chuangyue Huikang from August 27, 2025, to November 26, 2025, by a total of up to 46.33 million shares, accounting for 3% of the total share capital after excluding shares in the repurchase special account [2] - The reduction will consist of a maximum of 15.44 million shares through centralized bidding, representing 1.00%, and up to 30.89 million shares through block trading, representing 2.00% [2] - As of the announcement date, Philips holds 155 million shares in the company, which accounts for 10.01% of the total share capital and 10.04% of the total share capital after excluding shares in the repurchase special account [2]

证券代码：300451 证券简称：创业慧康 公告编号：2025-040 创业慧康科技股份有限公司 关于持股5%以上股东减持股份预披露公告 持股 5% 以上股东飞利浦（中国）投资有限公司保证信息披露的内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 持股 5%以上股东飞利浦（中国）投资有限公司计划自公告之日起十五个交 易日后的 3 个月内（在此期间如遇法律、法规规定的窗口期则不减持）以集中 竞价方式和大宗交易方式合计减持本公司股份不超过 46,332,793 股（含），占 剔除公司回购专用账户股份后总股本比例 3%，其中，通过集中竞价减持股份不 超过 15,444,264 股（含）；通过大宗交易减持，不超过 30,888,529 股（含）。 若期间公司有送股、资本公积金转增股份变动，该数量相应调整。 创业慧康科技股份有限公司（以下简称"公司"、"本公司"）于近日收 到持股 5%以上股东飞利浦（中国）投资有限公司（以下简称"飞利浦"）出具 的《股份减持计划的告知函》，现将有关情况公告如下： 一、股东的基本情况 1、股东名称 ...

Summary of Key Points Core Viewpoint - The stock of Chuangye Huikang (300451) has shown a slight increase, with a closing price of 5.95 yuan on August 1, 2025, reflecting a 2.76% rise, amidst mixed capital flows from different investor groups [1]. Financial Performance - Chuangye Huikang reported a main revenue of 290 million yuan in Q1 2025, a year-on-year decrease of 22.67% - The net profit attributable to shareholders was -15.64 million yuan, down 226.6% year-on-year - The company’s gross profit margin stands at 55.12% [4][5]. Capital Flow Analysis - On August 1, 2025, the net inflow of main funds was 18.34 million yuan, accounting for 3.04% of the total transaction amount - Retail investors experienced a net outflow of 16.92 million yuan, representing 2.8% of the total transaction amount [1][2]. Financing and Margin Trading - On August 1, 2025, the financing buy amounted to 48.18 million yuan, while the financing repayment was 65.73 million yuan, resulting in a net repayment of 17.55 million yuan - The total margin trading balance was 498 million yuan [1][2]. Industry Comparison - Chuangye Huikang's total market value is 9.171 billion yuan, compared to the software development industry average of 12.789 billion yuan - The company has a price-to-earnings ratio of -146.52, significantly lower than the industry average of 70.97 [4][5]. Institutional Ratings - In the last 90 days, three institutions have rated the stock, with two buy ratings and one hold rating - The average target price set by institutions is 6.13 yuan [5].

Core Insights - As of the last trading day on August 1, the pledge ratio of shareholders in Chuangyue Huikang reached 10.49% of the total share capital, ranking 906th in the two markets [1] - The total number of pledged shares amounts to 163 million, divided into 13 transactions, with a total market value of 967 million yuan [1] - Chuangyue Huikang focuses on the construction, research, and innovative services of healthcare information technology, offering a range of products including hospital information application software and various cloud platforms [1] - The company's stock has seen a significant increase of 72.46% over the past year [1] Company Overview - Chuangyue Huikang Technology Co., Ltd. specializes in healthcare information technology [1] - Key products include hospital information application software services, public health information application software services, and various cloud solutions [1] - The company is led by Chairman Zhang Lvzhen and General Manager Chen Zhongyang [1]

Group 1 - The "Regulations on Government Data Sharing" will be implemented on August 1, 2025, aiming to enhance the security, order, and efficiency of government data sharing, thereby improving digital governance and public service effectiveness [1] - The regulations fill a legislative gap in China's government data sharing sector and establish a clear management system, addressing the "data island" issue [1] - The regulations are expected to significantly benefit the government data market by optimizing sharing processes and improving data supply efficiency [1] Group 2 - Companies involved in public data authorized operations include China Mobile, China Telecom, China Unicom, Deep Sanda A, Yihualu, Taiji Co., and Guangdian Yuntong [2] - In the financial services sector, companies such as Hengsheng Electronics and Zhongke Ruankai are noted [2] - In the trade and circulation sector, Shanghai Steel Union is mentioned, while in healthcare, companies like Zhongke Jiangnan, Chuangye Huikang, Jiuyuan Yinhai, and Wanda Information are highlighted [2] - In transportation, Shenzhou Holdings and COSCO Shipping Technology are identified [2]

创业慧康最新一期业绩显示，截至2025一季报，公司营业总收入2.90亿元、同比减少22.67%，归属净利 润1564.74万元，同比减少226.60%，扣非净利润2795.93万元，同比减少389.48%，流动比率2.758、速动 比率2.423、资产负债率19.82%。 资金流向方面，今日主力资金净流入2134.31万元，占比成交额5.32%。其中，超大单净流入2.91万元、 占成交额0.01%，大单净流入2131.40万元、占成交额5.32%，中单净流出流入188.17万元、占成交额 0.47%，小单净流出2322.48万元、占成交额5.79%。 金融界消息 截至2025年7月30日收盘，创业慧康（300451）报收于5.79元，下跌0.86%，换手率4.52%， 成交量69.06万手，成交金额4.01亿元。 来源：金融界 天眼查商业履历信息显示，创业慧康科技股份有限公司，成立于1997年，位于杭州市，是一家以从事软 件和信息技术服务业为主的企业。企业注册资本154912.4692万人民币，实缴资本154912.4692万人民 币。公司法定代表人为张吕峥。 通过天眼查大数据分析，创业慧康科技股份有限公司共 ...

Core Viewpoint - The company, Chuangye Huikang, is transforming from a traditional IT service provider to a technology cloud ecosystem enterprise in the healthcare sector, focusing on AI integration to enhance efficiency and innovate healthcare services [2][11]. Company Overview - Chuangye Huikang Technology Co., Ltd. was established in 1997 and specializes in information services and innovations in the healthcare sector, covering various smart scenarios such as smart healthcare, health insurance, and elder care [2]. - The company has over 40 branches nationwide and serves nearly 7,000 users across more than 30 provinces and municipalities in China [2]. Role of AI in Business - AI is positioned as a core component in the company's "AI + Healthcare" strategy, serving as an efficiency tool, product upgrade engine, and new business incubator [4]. - AI significantly enhances product development and implementation efficiency, exemplified by the self-developed low-code platform CodeEase, which reduces development cycles and costs [4]. - The AI system "Huikang Cloud Hub" improves operational efficiency and automation in various healthcare scenarios [4]. Product Innovations - The company has developed the AI assistant "MedCopilot," which automates the generation of standardized medical records, thereby increasing efficiency in clinical diagnosis [5]. - The "Key Patient Precision Tracking System (APTS)" utilizes AI to identify high-risk patients and facilitate proactive health management [5]. - The company is advancing the "Agent + HIS" model to create intelligent hospital information systems [5]. Successful AI Application Case - The APTS system was successfully implemented at Taizhou Enze Medical Center, tracking over 3,000 key patients and improving early diagnosis rates by 42% [8]. - The system faced challenges in data governance and integration due to the complexity of medical data, which the company addressed by developing a microservice-based information system [8]. Data, Computing Power, and Algorithm Challenges - The company collaborates with the Hangzhou AI Computing Center to enhance computing power for AI model training [9]. - It has partnered with Huawei to create a new smart healthcare application ecosystem leveraging powerful computing capabilities [9]. - The company is also focused on customized algorithm development for various medical scenarios through partnerships with academic institutions [10]. Industry Transformation - AI is reshaping the healthcare software industry, evolving traditional systems into intelligent medical partners that integrate various functions [11]. - The company is leveraging its extensive industry experience to ensure successful AI application deployment across numerous hospitals [12]. Data Resource Strategy - High-quality data is crucial for training medical AI models, and the company has established partnerships with nearly 500 hospitals to accumulate rich data resources [13]. - The company has also become a member of the Guangzhou Data Exchange as a "transaction supplier" [13]. Strategic Collaborations - The company is building an AI + healthcare ecosystem through strategic partnerships, including collaborations with Zhejiang University for AI model development [14]. - It has achieved full domestic adaptation of its medical AI models and products, integrating various core components [14]. Implementation Across Hospitals - Chuangye Huikang has implemented AI solutions in over 30 hospitals, enhancing clinical decision support, patient tracking, and operational management [15]. Governance Mechanisms - The company emphasizes compliance with data privacy and algorithm application rules, ensuring adherence to industry standards [16]. Future Outlook - The company recognizes the challenges in the "AI + Healthcare" development path and is committed to continuous investment and collaboration to drive technological breakthroughs [17].

Core Viewpoint - The stock price of Chuangye Huikang reached 5.84 yuan as of July 29, 2025, reflecting a 0.34% increase from the previous trading day [1] Company Overview - Chuangye Huikang operates in the software development industry, focusing on healthcare information technology. Its business includes medical software development, system integration, and technical services [1] - The company is registered in Zhejiang Province, China [1] Market Performance - On July 29, 2025, the trading volume for Chuangye Huikang was 504,988 hands, with a total transaction amount of 291 million yuan [1] - The net inflow of main funds into the company on the same day was 1.3612 million yuan [1] - The current total market capitalization of Chuangye Huikang is 9.047 billion yuan, while the circulating market capitalization is 8.916 billion yuan [1]